Cel Our novel OMiProbe (Optical Fibre Micro Probe) is an optical device that allows quantitative cellular processes studies, even inside a single cell, and carries the disruptive potential for real-time, ‘in-vivo’ cancer diagnosis. At the current stage of development, with a diameter of less than 6 µm and a biologically active (antibodies) coating applied at the tip of the fibre optic probe, we are able to perform cellular level spectral identification of certain types of carcinomas, specifically breast cancer. (Carcinomas type of cancer comprise 80% to 90% of all cancers)The state of the art methods of cancer diagnosis require cutting/extracting tissue sample in a process called a biopsy, and consequently make non-destructive and live observations impossible. We believe OMiProbe technology offers an alternative to the destructive process of biopsy, and presents a safe, minimally invasive method for instantaneous cancer diagnosis and identification. With the OMiProbe, tissue may be examined ‘in vivo’ by insertion of the needle-sized OMiProbe into the suspected tissue, on live patients during standard medical examination, or during surgery. For better understanding and curing of cancer, early detection and diagnosis play a critical role. Cancer is in many cases treatable, and early detection increases the chance of cure substantially. However, it is not sufficient to define if the patient is ill or not. A more careful and prompt identification and examination of ill cells of the patient are needed to determine optimal treatment and approach. Today, such studies are difficult to quantify and impossible to realize non-destructively and in real-time. However, InPhoTech’s OMiProbe may allow to do just that. Dziedzina nauki medycyna i nauki o zdrowiunauki o zdrowiuzdrowie publiczne i środowiskowemedycyna i nauki o zdrowiumedycyna klinicznachirurgiamedycyna i nauki o zdrowiumedycyna klinicznaonkologiarak piersinauki społeczneekonomia i biznesekonomiazrównoważona gospodarkanauki przyrodniczenauki fizyczneoptykaświatłowody Program(-y) H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Temat(-y) SMEInst-01-2016-2017 - Open Disruptive Innovation Scheme Zaproszenie do składania wniosków H2020-SMEInst-2016-2017 Zobacz inne projekty w ramach tego zaproszenia Szczegółowe działanie H2020-SMEINST-1-2016-2017 System finansowania SME-1 - SME instrument phase 1 Koordynator INPHOTECH SP ZOO Wkład UE netto € 50 000,00 Adres Ul. poznańska 400 05-850 Ołtarzew Polska Zobacz na mapie Region Makroregion województwo mazowieckie Warszawski stołeczny Warszawski zachodni Rodzaj działalności Private for-profit entities (excluding Higher or Secondary Education Establishments) Linki Kontakt z organizacją Opens in new window Strona internetowa Opens in new window Uczestnictwo w unijnych programach w zakresie badań i innowacji Opens in new window sieć współpracy HORIZON Opens in new window Środki z innych źródeł € 21 429,00
